DB
Danielle Brill Raymond James Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Disc Medicine
IRON
$2.11B
| $60.76 | $86 |
42%
upside
| Buy | 1 month ago |
|
2
Alnylam Pharmaceuticals
ALNY
$59.2B
| $452 | $385 |
15%
downside
| Buy | 1 month ago |
|
3
Harmony Biosciences
HRMY
$2.07B
| $35.99 | $48 |
33%
upside
| Buy | 1 month ago |
|
|
PVLA
4
Palvella Therapeutics, Inc. Common Stock
PVLA
$616M
| $55.68 | $56 |
1%
upside
| Buy | 1 month ago |
|
|
TECX
5
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $16.80 | $64 |
281%
upside
| Buy | 1 month ago |
|
6
Neurocrine Biosciences
NBIX
$14.3B
| $144.10 | $163 |
13%
upside
| Buy | 1 month ago |
|
7
BridgeBio Pharma
BBIO
$10.2B
| $53.38 | $66 |
24%
upside
| Buy | 1 month ago |
|
|
CNTA
8
Centessa Pharmaceuticals
CNTA
$2.11B
| $15.73 | $30 |
91%
upside
| Buy | 1 month ago |
|
|
JCAP
9
Jefferson Capital, Inc. Common Stock
JCAP
$1.2B
| $18.58 | $24 |
29%
upside
| Buy | 1 month ago |
|
10
uniQure
QURE
$985M
| $17.95 | $52 |
190%
upside
| Strong Buy | 9 months ago |
|
|
TECX
11
Tectonic Therapeutic, Inc. Common Stock
TECX
$314M
| $16.80 | $65 |
287%
upside
| Outperform | 9 months ago |
|
12
BioMarin Pharmaceuticals
BMRN
$11.1B
| $57.77 | $79 |
37%
upside
| Outperform | 11 months ago |
|
13
Regenxbio
RGNX
$490M
| $9.71 | $18 |
85%
upside
| Outperform | 11 months ago |
|
|
14
Neurocrine Biosciences
NBIX
$14.3B
| $144.10 | $155 |
8%
upside
| Outperform | 11 months ago |
|
15
Immunovant
IMVT
$2.99B
| $17.14 | $36 |
110%
upside
| Outperform | 11 months ago |
|
|
16
Harmony Biosciences
HRMY
$2.07B
| $35.99 | $40 |
11%
upside
| Outperform | 11 months ago |
|
17
Sarepta Therapeutics
SRPT
$1.96B
| $18.71 | $150 |
702%
upside
| Outperform | 11 months ago |
|
18
argenx
ARGX
$45.9B
| $750.78 | $605 |
19%
downside
| Strong Buy | 11 months ago |
|
19
Xenon Pharmaceuticals
XENE
$3.02B
| $39.21 | $50 |
28%
upside
| Outperform | 11 months ago |
|
20
Agios Pharmaceuticals
AGIO
$2.09B
| $36.01 | $51 |
42%
upside
| Outperform | 11 months ago |
|
|
21
Disc Medicine
IRON
$2.11B
| $60.76 | $43 |
29%
downside
| Outperform | 1 year ago |
|